Israel Englander Summit Therapeutics Inc. Call Options Transaction History

Millennium Management LLC

  • $192 Billion
  • Q2 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$16.64 - $36.7 $282,880 - $623,900
-17,000 Reduced 16.83%
84,000 $1.79 Million
Q1 2025

May 15, 2025
BUY
$16.65 - $23.76 $1.43 Million - $2.04 Million
86,000 Added 573.33%
101,000 $1.95 Million
Q4 2024

Feb 14, 2025
SELL
$17.52 - $23.46 $7,008 - $9,384
-400 Reduced 2.6%
15,000 $267,000
Q3 2024

Nov 14, 2024
BUY
$6.89 - $31.93 $106,106 - $491,722
15,400 New
15,400 $337,000

Others Institutions Holding SMMT

# of Institutions
259
Shares Held
90.4M
Call Options Held
4.67M
Put Options Held
3.15M
View Full List

About Summit Therapeutics Inc.

SMMT Quotes by TradingView
  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $5.17B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email